Spanish orthopedic industry rejects new standardization law on prescription access

July 29, 2016

BioWorld briefs for Nov. 27, 2024.

Today's news in brief

BioWorld MedTech briefs for December 2, 2024.

Illustration of man holding magnifying glass to human body model showing muscle anatomy

In muscular dystrophies, gene therapies race the clock

Since the isolation of the gene that causes Duchenne muscular dystrophy (DMD), scientists have progressed in understanding the mechanisms that lead to muscular...

AI-generated illustration of heart and metabolic impact

Bridgebio, with FDA approval, faces Pfizer in ATTR

BioWorld

With the U.S. FDA approval of Attruby (acoramidis) for transthyretin amyloidosis with cardiomyopathy (ATTR-CM), Bridgebio Pharma Inc. is taking on an industry...

Apollo signs near-$1B deal for Sunshine’s FGF21/GLP-1 injection

BioWorld Asia

Apollo Therapeutics Group Ltd. and Sunshine Lake Pharma Co. Ltd. inked a potential $938 million licensing deal for APL-18881 (HEC-88473), Sunshine’s dual...

M lisande Rouger

ARTICLES

Spanish orthopedic industry rejects new standardization law on prescription access

Today's news in brief

Today's news in brief

In muscular dystrophies, gene therapies race the clock

Bridgebio, with FDA approval, faces Pfizer in ATTR

Apollo signs near-$1B deal for Sunshine’s FGF21/GLP-1 injection